Cargando…

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

AIMS: Cardiac microRNA-132-3p (miR-132) levels are increased in patients with heart failure (HF) and mechanistically drive cardiac remodelling processes. CDR132L, a specific antisense oligonucleotide, is a first-in-class miR-132 inhibitor that attenuates and even reverses HF in preclinical models. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Täubel, Jörg, Hauke, Wilfried, Rump, Steffen, Viereck, Janika, Batkai, Sandor, Poetzsch, Jenny, Rode, Laura, Weigt, Henning, Genschel, Celina, Lorch, Ulrike, Theek, Carmen, Levin, Arthur A, Bauersachs, Johann, Solomon, Scott D, Thum, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954267/ https://www.ncbi.nlm.nih.gov/pubmed/33245749 http://dx.doi.org/10.1093/eurheartj/ehaa898

Ejemplares similares

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
por: Batkai, Sandor, et al.
Publicado: (2020)

Preclinical development of a miR-132 inhibitor for heart failure treatment
por: Foinquinos, Ariana, et al.
Publicado: (2020)

Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry
por: Herkt, Markus, et al.
Publicado: (2020)

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
por: Ucar, Ahmet, et al.
Publicado: (2012)

Circulating micrornas as potential biomarkers of aerobic exercise capacity
por: Mooren, Frank C., et al.
Publicado: (2013)

Studying Interactions between 2’-O-Me-Modified Inhibitors and MicroRNAs Utilizing Microscale Thermophoresis
por: Herkt, Markus, et al.
Publicado: (2019)

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury
por: Jansing, Johanna Christine, et al.
Publicado: (2020)

Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study
por: Ferber, Georg, et al.
Publicado: (2015)

Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
por: Lorch, Ulrike, et al.
Publicado: (2014)

Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy
por: Catapano, Francesco, et al.
Publicado: (2016)

Antisense miR-132 blockade via the AChE-R splice variant mitigates cortical inflammation
por: Mishra, Nibha, et al.
Publicado: (2017)

Blinding Is Seeing: A Single-Centre Study Into the Viability of Auto-Injectors for Blinded-Drug Administration in Randomised Controlled Trials
por: Aggarwal, Vishal, et al.
Publicado: (2023)

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy
por: Viereck, Janika, et al.
Publicado: (2020)

Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open‐Label, Randomized Crossover Studies in Healthy Japanese Volunteers
por: Lorch, Ulrike, et al.
Publicado: (2020)

The Reliability of Auto-Injectors in Clinical Use: A Systematic Review
por: Dostal, Petr, et al.
Publicado: (2023)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
por: Täubel, Jörg, et al.
Publicado: (2016)

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval – A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity
por: Täubel, Jörg, et al.
Publicado: (2015)

Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects
por: Täubel, Jörg, et al.
Publicado: (2016)

Memorandum: expérience S132
por: Binon, Freddy G, et al.
Publicado: (1974)

Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
por: Coates, Simon, et al.
Publicado: (2020)

Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine
por: Mester-Tonczar, Julia, et al.
Publicado: (2020)

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart
por: Jazbutyte, Virginija, et al.
Publicado: (2012)

In vivo uptake of antisense oligonucleotide drugs predicted by ab initio quantum mechanical calculations
por: Hansen, Henrik Frydenlund, et al.
Publicado: (2021)

132nd SPSC Meeting
Publicado: (2018)

132nd LHCC Meeting
Publicado: (2017)

Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters
por: Sonnenschein, Kristina, et al.
Publicado: (2021)

Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5′-Directed Mismatch Repair
por: Genschel, Jochen, et al.
Publicado: (2009)

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
por: Mullens, Wilfried, et al.
Publicado: (2023)

Summary of Sloan symposium: healthy buildings 2015-Europe
por: Levin, Hal, et al.
Publicado: (2015)

Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study
por: Luo, Huanyuan, et al.
Publicado: (2021)

Der Mann ohne Worte
por: Poetzsch, Marian C.
Publicado: (2015)

Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury
por: Kölling, Malte, et al.
Publicado: (2018)

Telomerase therapy attenuates cardiotoxic effects of doxorubicin
por: Chatterjee, Shambhabi, et al.
Publicado: (2021)

Confirmation of the Cardiac Safety of PGF(2α) Receptor Antagonist OBE022 in a First‐in‐Human Study in Healthy Subjects, Using Intensive ECG Assessments
por: Täubel, Jörg, et al.
Publicado: (2018)

Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges
por: Mundy, Charles, et al.
Publicado: (2023)

Measurements with the 132/90 optics in LEP
por: Verdier, A, et al.
Publicado: (2000)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ks85ai6tiqsn11jv8qoc14hv1d